Mangrove Partners IM LLC purchased a new position in Teleflex Incorporated (NYSE:TFX – Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 256,726 shares of the medical technology company’s stock, valued at approximately $31,331,000. Teleflex makes up about 2.6% of Mangrove Partners IM LLC’s investment portfolio, making the stock its 17th biggest holding.
A number of other hedge funds have also made changes to their positions in TFX. Banque Cantonale Vaudoise lifted its position in shares of Teleflex by 82.5% in the fourth quarter. Banque Cantonale Vaudoise now owns 250 shares of the medical technology company’s stock worth $31,000 after purchasing an additional 113 shares in the last quarter. V Square Quantitative Management LLC purchased a new stake in shares of Teleflex in the fourth quarter worth approximately $37,000. UMB Bank n.a. lifted its position in shares of Teleflex by 57.1% in the fourth quarter. UMB Bank n.a. now owns 311 shares of the medical technology company’s stock worth $38,000 after purchasing an additional 113 shares in the last quarter. Sound Income Strategies LLC purchased a new stake in shares of Teleflex in the fourth quarter worth approximately $45,000. Finally, Kestra Advisory Services LLC purchased a new stake in shares of Teleflex in the fourth quarter worth approximately $45,000. 95.62% of the stock is owned by hedge funds and other institutional investors.
Analyst Ratings Changes
A number of analysts have recently issued reports on TFX shares. Zacks Research raised shares of Teleflex from a “strong sell” rating to a “hold” rating in a research report on Tuesday, April 28th. Piper Sandler raised shares of Teleflex from a “neutral” rating to an “overweight” rating and raised their price objective for the company from $140.00 to $160.00 in a research report on Monday, June 8th. Raymond James Financial reaffirmed an “outperform” rating and set a $150.00 price objective on shares of Teleflex in a research report on Friday, May 8th. Wells Fargo & Company raised their price objective on shares of Teleflex from $130.00 to $138.00 and gave the company an “equal weight” rating in a research report on Friday, May 8th. Finally, Mizuho set a $140.00 price objective on shares of Teleflex in a research report on Friday, May 8th. Four research analysts have rated the stock with a Buy rating, five have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, Teleflex has an average rating of “Hold” and an average price target of $146.00.
Teleflex Stock Down 1.6%
TFX stock opened at $127.98 on Wednesday. The company has a debt-to-equity ratio of 0.82, a current ratio of 2.55 and a quick ratio of 2.03. Teleflex Incorporated has a 52-week low of $100.18 and a 52-week high of $139.67. The company has a 50-day moving average of $129.11 and a two-hundred day moving average of $119.17. The stock has a market capitalization of $5.67 billion, a price-to-earnings ratio of -5.61, a price-to-earnings-growth ratio of 0.97 and a beta of 0.82.
Teleflex (NYSE:TFX – Get Free Report) last released its quarterly earnings results on Thursday, May 7th. The medical technology company reported $1.39 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.21 by $0.18. Teleflex had a negative net margin of 35.88% and a positive return on equity of 13.29%. The company had revenue of $548.30 million during the quarter, compared to analysts’ expectations of $536.91 million. During the same period in the prior year, the company earned $1.44 earnings per share. The business’s quarterly revenue was up 32.3% compared to the same quarter last year. Teleflex has set its FY 2026 guidance at 6.250-6.550 EPS. As a group, equities research analysts anticipate that Teleflex Incorporated will post 6.7 EPS for the current year.
Teleflex Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Tuesday, June 30th. Shareholders of record on Monday, May 25th will be issued a dividend of $0.34 per share. This represents a $1.36 dividend on an annualized basis and a yield of 1.1%. The ex-dividend date is Friday, May 22nd. Teleflex’s dividend payout ratio is -5.96%.
About Teleflex
Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.
The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.
Read More
- Five stocks we like better than Teleflex
- Gravity Check: Houston, SpaceX Has a Valuation Problem
- Strategy’s Bitcoin Rally Has a Hidden Engine
- Okta’s AI Moment May Be Bigger Than Investors Realize
- 3 Rate-Ready Stocks for the New Fed Chair’s First Big Test
Want to see what other hedge funds are holding TFX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teleflex Incorporated (NYSE:TFX – Free Report).
Receive News & Ratings for Teleflex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex and related companies with MarketBeat.com's FREE daily email newsletter.
